Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Mol Cell Biochem
2015 Jan 01;3981-2:73-81. doi: 10.1007/s11010-014-2206-0.
Show Gene links
Show Anatomy links
Erythropoietin protects red blood cells from TRAIL1-induced cell death during red blood cell transition in Xenopus laevis.
Tamura K
,
Takamatsu N
,
Ito M
.
???displayArticle.abstract???
In anuran amphibians, larval red blood cells (RBCs) are replaced by adult-type RBCs during metamorphosis. We previously showed that tumor necrosis factor-related apoptosis-inducing ligand 1 (TRAIL1) induces apoptosis in larval-, but not adult-type RBCs in Xenopus laevis. We also found that protein kinase C (PKC) activation is involved in establishing resistance to TRAIL1-induced apoptosis in adult-type RBCs. Here, we investigated whether erythropoietin (EPO), which induces PKC activation in mammalian erythroblasts, is involved in the RBC transition in X. laevis. RT-PCR analysis revealed that epo mRNA was upregulated in the lung, from the metamorphic climax (stage 60) onward. In an RBC culture system, EPO pretreatment significantly attenuated the TRAIL1-induced death of larval- and adult-type RBCs isolated from tadpoles and adults, probably due partly to PKC activation. In samples from froglets undergoing RBC transition, which included both larval- and adult-type RBCs, EPO exhibited a stronger protective effect on the adult-type than the larval-type RBCs. Newly differentiated RBCs isolated from tadpoles treated with a hemolytic reagent were more resistant to TRAIL1-induced cell death than non-treated controls. These results suggest that EPO functions to protect adult-type RBCs from TRAIL1-induced cell death during RBC transition, and that the protective effect might decrease as RBCs age.
Aizawa,
Expression of erythropoietin receptor-like molecule in Xenopus laevis and erythrocytopenia upon administration of its recombinant soluble form.
2005, Pubmed,
Xenbase
Aizawa,
Expression of erythropoietin receptor-like molecule in Xenopus laevis and erythrocytopenia upon administration of its recombinant soluble form.
2005,
Pubmed
,
Xenbase
Alfrey,
Neocytolysis: physiological down-regulator of red-cell mass.
1997,
Pubmed
Baker,
Hematopoietic cytokine receptor signaling.
2007,
Pubmed
Haslauer,
Erythropoietin- and stem cell factor-induced DNA synthesis in normal human erythroid progenitor cells requires activation of protein kinase Calpha and is strongly inhibited by thrombin.
1999,
Pubmed
Huang,
The N-terminal domain of Janus kinase 2 is required for Golgi processing and cell surface expression of erythropoietin receptor.
2001,
Pubmed
Kischkel,
Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5.
2000,
Pubmed
Mirandola,
PKCepsilon controls protection against TRAIL in erythroid progenitors.
2006,
Pubmed
Mori,
Activation of extracellular signal-regulated kinases ERK1 and ERK2 induces Bcl-xL up-regulation via inhibition of caspase activities in erythropoietin signaling.
2003,
Pubmed
Myklebust,
Protein kinase C-alpha isoform is involved in erythropoietin-induced erythroid differentiation of CD34(+) progenitor cells from human bone marrow.
2000,
Pubmed
Nishikawa,
T3-hydrocortisone synergism on adult-type erythroblast proliferation and T3-mediated apoptosis of larval-type erythroblasts during erythropoietic conversion in Xenopus laevis.
1999,
Pubmed
,
Xenbase
Nogawa-Kosaka,
Identification of erythroid progenitors induced by erythropoietic activity in Xenopus laevis.
2011,
Pubmed
,
Xenbase
Nogawa-Kosaka,
Structural and biological properties of erythropoietin in Xenopus laevis.
2010,
Pubmed
,
Xenbase
Pitti,
Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family.
1996,
Pubmed
Ribeil,
Hsp70 regulates erythropoiesis by preventing caspase-3-mediated cleavage of GATA-1.
2007,
Pubmed
Rice,
Neocytolysis contributes to the anemia of renal disease.
1999,
Pubmed
Rice,
Neocytolysis on descent from altitude: a newly recognized mechanism for the control of red cell mass.
2001,
Pubmed
Rice,
The negative regulation of red cell mass by neocytolysis: physiologic and pathophysiologic manifestations.
2005,
Pubmed
Richmond,
Turning cells red: signal transduction mediated by erythropoietin.
2005,
Pubmed
Risso,
Red blood cell senescence and neocytolysis in humans after high altitude acclimatization.
2007,
Pubmed
Seol,
Signaling events triggered by tumor necrosis factor-related apoptosis-inducing ligand (TRAIL): caspase-8 is required for TRAIL-induced apoptosis.
2001,
Pubmed
Silva,
Erythropoietin can induce the expression of bcl-x(L) through Stat5 in erythropoietin-dependent progenitor cell lines.
1999,
Pubmed
Socolovsky,
Fetal anemia and apoptosis of red cell progenitors in Stat5a-/-5b-/- mice: a direct role for Stat5 in Bcl-X(L) induction.
1999,
Pubmed
Sprick,
FADD/MORT1 and caspase-8 are recruited to TRAIL receptors 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2.
2000,
Pubmed
Tamura,
Tumor necrosis factor-related apoptosis-inducing ligand 1 (TRAIL1) enhances the transition of red blood cells from the larval to adult type during metamorphosis in Xenopus.
2010,
Pubmed
,
Xenbase
Wickrema,
Abundance and stability of erythropoietin receptor mRNA in mouse erythroid progenitor cells.
1991,
Pubmed
Wiley,
Identification and characterization of a new member of the TNF family that induces apoptosis.
1995,
Pubmed
Witthuhn,
JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietin.
1993,
Pubmed
Yang,
Preconditioning with erythropoietin protects against subsequent ischemia-reperfusion injury in rat kidney.
2003,
Pubmed
von Lindern,
Protein kinase C alpha controls erythropoietin receptor signaling.
2000,
Pubmed
